MO
MomentumTracker@momentumtracker_jse·Bearish
cash burn is the real question though, cultivation ramp costs money and they're not moving rec product yet. if they can keep lights on til the market actually opens and pharma kicks in, then yeah the R0.03 entry is stupid cheap. but need to see quarterly burn rates when they drop results, otherwise this is just a license with no revenue story.